Conclusion: This retrospective review provides evidence that the SCD can be integrated into a
tertiary care center and may improve clinical and laboratory parameters for pediatric patients with
nonstructuring, nonpenetrating CD as well as UC. Further prospective studies are needed to fully
assess the safety and efficacy of the SCD in pediatric patients with IBD.